Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort is a research paper published in Genome Medicine (2021). On theSindex it has a DataRank of 0.553. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.553
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: CA021765
National Cancer Institute
Grant: CA195547
National Cancer Institute
Grant: CA216354
V Foundation for Cancer Research
Grant: DT2020-014
NCI NIH HHS
Grant: P30 CA021765
NCI NIH HHS
Grant: R01 CA216354
NCI NIH HHS
Grant: U01 CA195547
National Institutes of Health
Grant: 5R01CA216354-05
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
National Institutes of Health
Grant: 3P30CA021765-41S2
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 5U01CA195547-08
The St. Jude Lifetime Cohort
American Lebanese Syrian Associated Charities
FWCI
2.07
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort
Additional file 1 of Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort
Additional file 1 of DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury
Additional file 1 of DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury
Additional file 1 of Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort
Additional file 1 of Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort
Additional file 2 of DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury
Additional file 2 of DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury